What is the recommended intravenous (IV) dose of ceftriaxone (a third-generation cephalosporin antibiotic) for a urinary tract infection (UTI) in a 99-year-old female (YOF) with chronic kidney disease (CKD) and impaired renal function, as indicated by an estimated glomerular filtration rate (eGFR) of 43?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

For a 99-year-old female with CKD and an eGFR of 43 who requires IV ceftriaxone for a UTI, the recommended dose is 1-2 grams IV once daily, as ceftriaxone is primarily eliminated through biliary excretion rather than renal clearance 1.

Key Considerations

  • No dosage adjustment is necessary for ceftriaxone in this patient despite her reduced renal function.
  • The duration of therapy typically ranges from 7-14 days depending on the severity of the infection and clinical response.
  • For complicated UTIs in elderly patients with comorbidities, a 10-14 day course is often appropriate.

Monitoring and Precautions

  • Monitor renal function during treatment and assess clinical response after 48-72 hours.
  • Watch for potential side effects including diarrhea, elevated liver enzymes, and allergic reactions.
  • If the patient has a history of severe penicillin allergy, caution is warranted due to potential cross-reactivity.
  • Ensure adequate hydration during treatment to support both renal function and recovery from the UTI.

Additional Considerations

  • Ceftriaxone therapy should be considered carefully in patients with complicated UTIs due to the possibility of enterococcal re-infection and consequent prolonged hospital stay 2.
  • Alternative therapies, such as amoxicillin-clavulanate, may be considered for ceftriaxone non-susceptible UTIs 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.